Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 9797021, 10 pages
http://dx.doi.org/10.1155/2016/9797021
Research Article

Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis

1Department of Pharmacology, Medical School, Université de Sherbrooke, 3001 12th Avenue North, Sherbrooke, QC, Canada J1H 5N4
2Department of Pediatrics, Program of Immunology and Allergology, Medical School, Université de Sherbrooke, 3001 12th Avenue North, Sherbrooke, QC, Canada J1H 5N4
3Department of Medical Biochemistry and Microbiology, Uppsala University BMC, Box 582, 75123 Uppsala, Sweden
4Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, P.O. Box 7070, 75007 Uppsala, Sweden

Received 20 March 2016; Revised 13 June 2016; Accepted 21 July 2016

Academic Editor: Sandra Helena Penha Oliveira

Copyright © 2016 Louisane Desbiens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Frenzel and O. Hermine, “Mast cells and inflammation,” Joint Bone Spine, vol. 80, no. 2, pp. 141–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. L. St John and S. N. Abraham, “Innate immunity and its regulation by mast cells,” Journal of Immunology, vol. 190, no. 9, pp. 4458–4463, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. H. Secor, W. E. Secor, C.-A. Gutekunst, and M. A. Brown, “Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis,” The Journal of Experimental Medicine, vol. 191, no. 5, pp. 813–822, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. B. A. Sayed, M. E. Walker, and M. A. Brown, “Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis,” Journal of Immunology, vol. 186, no. 6, pp. 3294–3298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. G. D. Gregory, M. Robbie-Ryan, V. H. Secor, J. J. Sabatino Jr., and M. A. Brown, “Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis,” European Journal of Immunology, vol. 35, no. 12, pp. 3478–3486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Costanza, M. P. Colombo, and R. Pedotti, “Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis,” International Journal of Molecular Sciences, vol. 13, no. 11, pp. 15107–15125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. L. Christy, M. E. Walker, M. J. Hessner, and M. A. Brown, “Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE,” Journal of Autoimmunity, vol. 42, pp. 50–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Brown, M. B. Tanzola, and M. Robbie-Ryan, “Mechanisms underlying mast cell influence on EAE disease course,” Molecular Immunology, vol. 38, no. 16-18, pp. 1373–1378, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. L. Watson, K. Westland, and J. D. Pollard, “An electrophysiological and histological study of trypsin induced demyelination,” Journal of the Neurological Sciences, vol. 126, no. 2, pp. 116–125, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. A. E. Russi, M. E. Walker-Caulfield, and M. A. Brown, “Mast cell inflammasome activity in the meninges regulates EAE disease severity,” Clinical Immunology, 2016. View at Publisher · View at Google Scholar
  11. S. Piconese, M. Costanza, S. Musio et al., “Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice,” Laboratory Investigation, vol. 91, no. 4, pp. 627–641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. B. Feyerabend, A. Weiser, A. Tietz et al., “Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity,” Immunity, vol. 35, no. 5, pp. 832–844, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. L. Bennett, M.-R. Blanchet, L. Zhao et al., “Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis,” The Journal of Immunology, vol. 182, no. 9, pp. 5507–5514, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Wu, H.-C. Kuo, and G. G. Deng, “Serine proteases and cardiac function,” Biochimica et Biophysica Acta (BBA)—Proteins and Proteomics, vol. 1751, no. 1, pp. 82–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. K. Andersson, U. Karlson, and L. Hellman, “The extended cleavage specificity of the rodent β-chymases rMCP-1 and mMCP-4 reveal major functional similarities to the human mast cell chymase,” Molecular Immunology, vol. 45, no. 3, pp. 766–775, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Hendrix, P. Kramer, D. Pehl et al., “Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4,” The FASEB Journal, vol. 27, no. 3, pp. 920–929, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Scandiuzzi, W. Beghdadi, E. Daugas et al., “Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis,” The Journal of Immunology, vol. 185, no. 1, pp. 624–633, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. L. L. Reber, F. Daubeuf, G. Pejler, M. Abrink, and N. Frossard, “Mast cells contribute to bleomycin-induced lung inflammation and injury in mice through a chymase/mast cell protease 4-dependent mechanism,” The Journal of Immunology, vol. 192, no. 4, pp. 1847–1854, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Houde, M.-D. Jamain, J. Labonté et al., “Pivotal role of mouse mast cell protease 4 in the conversion and pressor properties of big-endothelin-1,” The Journal of Pharmacology and Experimental Therapeutics, vol. 346, no. 1, pp. 31–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Semaan, L. Desbiens, M. Houde et al., “Chymase inhibitor-sensitive synthesis of endothelin-1 (1–31) by recombinant mouse mast cell protease 4 and human chymase,” Biochemical Pharmacology, vol. 94, no. 2, pp. 91–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Haufschild, S. G. Shaw, J. Kesselring, and J. Flammer, “Increased endothelin-1 plasma levels in patients with multiple sclerosis,” Journal of Neuro-Ophthalmology, vol. 21, no. 1, pp. 37–38, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Pache, H. J. Kaiser, N. Akhalbedashvili et al., “Extraocular blood flow and endothelin-1 plasma levels in patients with multiple sclerosis,” European Neurology, vol. 49, no. 3, pp. 164–168, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Jankowska-Lech, B. Terelak-Borys, I. Grabska-Liberek, W. Palasik, W. Bik, and E. Wolińska-Witort, “Decreased endothelin-1 plasma levels in multiple sclerosis patients: a possible factor of vascular dysregulation?” Medical Science Monitor, vol. 21, pp. 1066–1071, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Guo, S. K. Chung, C.-W. Siu et al., “Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis,” Journal of Neuroimmunology, vol. 276, no. 1-2, pp. 64–70, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Tchougounova, G. Pejler, and M. Åbrink, “The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover,” The Journal of Experimental Medicine, vol. 198, no. 3, pp. 423–431, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. D. Miller and W. J. Karpus, “Experimental autoimmune encephalomyelitis in the mouse,” Current Protocol of Immunology, chapter 15, Unit 15.1, 2007. View at Publisher · View at Google Scholar
  27. M. Gharagozloo, T. M. Mahvelati, E. Imbeault et al., “The nod-like receptor, Nlrp12, plays an anti-inflammatory role in experimental autoimmune encephalomyelitis,” Journal of Neuroinflammation, vol. 12, article 198, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Brahmachari, Y. K. Fung, and K. Pahan, “Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide,” The Journal of Neuroscience, vol. 26, no. 18, pp. 4930–4939, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Ohsawa, Y. Imai, Y. Sasaki, and S. Kohsaka, “Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity,” Journal of Neurochemistry, vol. 88, no. 4, pp. 844–856, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Wernersson and G. Pejler, “Mast cell secretory granules: armed for battle,” Nature Reviews Immunology, vol. 14, no. 7, pp. 478–494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Shin, B. Kang, N. Tanuma et al., “Intrathecal administration of endothelin-1 receptor antagonist ameliorates autoimmune encephalomyelitis in Lewis rats,” NeuroReport, vol. 12, no. 7, pp. 1465–1468, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. T. R. Hammond, B. McEllin, P. D. Morton, M. Raymond, J. Dupree, and V. Gallo, “Endothelin-B receptor activation in astrocytes regulates the rate of oligodendrocyte regeneration during remyelination,” Cell Reports, vol. 13, no. 10, pp. 2090–2097, 2015. View at Publisher · View at Google Scholar
  33. M. E. Walker, J. K. Hatfield, and M. A. Brown, “New insights into the role of mast cells in autoimmunity: evidence for a common mechanism of action?” Biochimica et Biophysica Acta—Molecular Basis of Disease, vol. 1822, no. 1, pp. 57–65, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Heuston and N. P. Hyland, “Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?” British Journal of Pharmacology, vol. 167, no. 4, pp. 732–740, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. B. E. Maryanoff, L. de Garavilla, M. N. Greco et al., “Dual inhibition of cathepsin G and chymase is effective in animal models of pulmonary inflammation,” American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 3, pp. 247–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Oyamada, C. Bianchi, S. Takai, L. M. Chu, and F. W. Sellke, “Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion,” The Journal of Pharmacology and Experimental Therapeutics, vol. 339, no. 1, pp. 143–151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. S. S. Palaniyandi, Y. Nagai, K. Watanabe et al., “Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats,” Experimental Biology and Medicine, vol. 232, no. 9, pp. 1213–1221, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. D'Haeseleer, R. Beelen, Y. Fierens et al., “Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 14, pp. 5654–5658, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Kerschensteiner, F. M. Bareyre, B. S. Buddeberg et al., “Remodeling of axonal connections contributes to recovery in an animal model of multiple sclerosis,” The Journal of Experimental Medicine, vol. 200, no. 8, pp. 1027–1038, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. S. E. Magnusson, G. Pejler, S. Kleinau, and M. Åbrink, “Mast cell chymase contributes to the antibody response and the severity of autoimmune arthritis,” The FASEB Journal, vol. 23, no. 3, pp. 875–882, 2009. View at Publisher · View at Google Scholar · View at Scopus